pipette
ESEspañol

Histologic Features and Clinical Outcomes of Lean Metabolic Dysfunction–Associated Steatotic Liver Disease

Leyla de Avila, Khalid M. AlNaamani, Μargarita Papatheodoridi, Salvatore Petta, Hannes Hagstrom, Seung Up Kim, Atsushi Nakajima, Javier Crespo, Laurent Castéra, Naim Alkhouri, Ming-Hua Zheng, Sombat Treeprasertsuk, Shalimar, Emmanuel Tsochatzis, Shenoy Kotacherry Trivikrama, Jian-Gao Fan, Stuart Keith Roberts, Khalid Alswat, Vincent Wai-Sun Wong, Yusuf Yilmaz, Winston Dunn, Sven Francque, Ahmed Cordie, Ming-Lung Yu, Mattias Ekstedt, George Boon‐Bee Goh, Claudia P. Oliveira, Mario Guimaraes Pessoa, Wah Kheong Chan, Marlen Ivon Castellanos Fernandez, Ajay Duseja, Juan Pablo Arab, George Papatheodoridis, Giada Sebastiani, Cristiane Villela-Nogueira, Roberta D’Ambrosio, Pietro Lampertico, A.G. (Onno) Holleboom, Arun Valsan, Mohamed El-Kassas, Takashi Kobayashi, Satoru Kakizaki, Cyrielle Caussy, Brian Pearlman, Nicola Pugliese, Johan Vessby, Narendra Singh Choudhary, Takumi Kawaguchi, Francesco Paolo Russo, Adrian Gadano and 10 more

Peer-reviewed journalReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
Conclusions and Relevance Lean MASLD represents a distinct phenotype with milder histologic disease but similar clinical outcomes compared with overweight/obese MASLD.

Appeared: Friday, October 2. JAMA. Peer-reviewed journal.

DOI: 10.1001/jama.2026.18491